AwardedSWEGoodsSEK 9,000,000
Denosumab
- Published
- Published 2 February 2026
- Deadline
- Closed 2 March 2026
Overview
Region Halland upphandlar sitt behov av denosumab i enlighet med bifogad sortimentsbilaga. Avtalet löper under en begränsad period till 2027-01-31 utan möjlighet till förlängning.
Key details
- Country
- SWE
- Status
- Awarded
- Category
- Goods
- Estimated value
- SEK 9,000,000
- Procedure
- Open
- Published
- 2 February 2026
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- SEK 1,437,583
- Award date
- 6 March 2026
- Amgen AB
- Celltrion Sweden AB
- Fresenius Kabi AB
- Gedeon Richter Nordics AB
- Medical Valley Invest AB
- Sandoz A/S
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 March 2026
Contract Notice
2 February 2026
Contracting authority
REGION HALLAND
Procuring entityHalmstad, SWE
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.